Family Medicine · Brooklyn, NY
NPI
1174592836
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
170 Avenue S
Brooklyn, NY, 11223
Phone (718) 382-8282
Groups this clinician bills Medicare through
Medicare paid, 2024
$63K
813 services
Medicare patients, 2024
87
Average age 76
Drug cost, 2024
$1.0M
5,305 prescriptions
Company payments, 2025
$3,044
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rimma Pichkar was code 99214 (office e&m - established), 370 times for 78 patients. In total Rimma Pichkar billed 813 services in 42 codes, and Medicare paid $63K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-12-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 370 | 78 | $104.00 | $38K |
| 99213 Office E&M - Established | Office | 204 | 71 | $73.96 | $15K |
| 99212 Office E&M - Established | Office | 63 | 32 | $41.14 | $2,592 |
| 36415 Venipuncture Blood Collection | Office | 35 | 29 | $7.42 | $260 |
| 96372 Injection Administration | Office | 29 | 12 | $12.98 | $377 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 19 | 19 | $146.86 | $2,790 |
| 93000 Electrocardiogram | Office | 14 | 13 | $13.22 | $185 |
By year: 2022 $123K for 2,325 services; 2023 $105K for 1,623 services; 2024 $63K for 813 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 35 | 29 | $7.42 | $260 |
Medicare prescription drug claims, 2024
In 2024, the drug Rimma Pichkar prescribed most often to Medicare patients was Atorvastatin Calcium, with 195 prescriptions and refills. In total Rimma Pichkar wrote 5,305 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 195 | 262 | 39 | $683 |
| Metformin Hcl Generic | 173 | 247 | 36 | $13K |
| Omeprazole Generic | 155 | 193 | 41 | $638 |
| Amlodipine Besylate Generic | 153 | 225 | 38 | $234 |
| Metoprolol Succinate Generic | 145 | 255 | 27 | $1,688 |
| Rosuvastatin Calcium Generic | 128 | 214 | 29 | $1,008 |
| Vascepa Icosapent Ethyl | 119 | 127 | 19 | $42K |
| Diclofenac Sodium Generic | 108 | 115 | 32 | $48K |
| Creon Lipase/Protease/Amylase | 99 | 104 | 22 | $108K |
| Levothyroxine Sodium Generic | 97 | 178 | 25 | $494 |
| Dexlansoprazole Dr Dexlansoprazole | 82 | 92 | 11 | $13K |
| Carvedilol Generic | 76 | 110 | 17 | $283 |
| Synthroid Levothyroxine Sodium | 72 | 125 | Under 11 | $5,326 |
| Metoprolol Tartrate Generic | 70 | 92 | Under 11 | $113 |
| Zenpep Lipase/Protease/Amylase | 64 | 65 | Under 11 | $63K |
Brand drugs: 1,398 claims; generic drugs: 3,808 claims; opioid claims: 20.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rimma Pichkar $3,044 ($3,044 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $806.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 15 | $806 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $789 |
| Amgen Inc. AMGN | 12 | $531 |
| Axsome Therapeutics, Inc. AXSM | 2 | $269 |
| Insmed, Inc. INSM | 1 | $150 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| Lilly USA, LLC LLY | 1 | $120 |
| Cumberland Pharmaceuticals, Inc. CPIX | 1 | $54.74 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $53.63 |
| Aimmune Therapeutics, Inc. | 2 | $51.83 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.